scispace - formally typeset
R

Rebecca Scroop

Researcher at Royal Adelaide Hospital

Publications -  17
Citations -  6126

Rebecca Scroop is an academic researcher from Royal Adelaide Hospital. The author has contributed to research in topics: Modified Rankin Scale & Stroke. The author has an hindex of 9, co-authored 12 publications receiving 4650 citations. Previous affiliations of Rebecca Scroop include Royal Australian and New Zealand College of Radiologists.

Papers
More filters
Journal ArticleDOI

Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection

TL;DR: In patients with ischemic stroke with a proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic recovery, and functional outcome.
Journal ArticleDOI

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

TL;DR: Tenecteplase before thrombectomy was associated with a higher incidence of reperfusion and better functional outcome than alteplase among patients with ischemic stroke treated within 4.5 hours after symptom onset.
Journal ArticleDOI

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Michael D. Hill, +776 more
- 14 Mar 2020 - 
TL;DR: Nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo, and this trial is registered with ClinicalTrials.gov, NCT02930018.
Journal ArticleDOI

Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

Bruce C.V. Campbell, +1296 more
- 01 Jan 2019 - 
TL;DR: Estimated ischaemic core volume was independently associated with functional independence and functional improvement but did not modify the treatment benefit of endovascular thrombectomy over standard medical therapy for improved functional outcome.
Journal ArticleDOI

Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK Part 2 randomized clinical trial

Bruce C.V. Campbell, +63 more
- 07 Apr 2020 - 
TL;DR: Among patients with large vessel occlusion ischemic stroke, a dose of 0.40 mg/kg of tenecteplase did not significantly improve cerebral reperfusion prior to endovascular thrombectomy, and the findings suggest that the0.40-mg/kg dose ofTenecte Plase does not confer an advantage over the 0.25-mg-kg dose.